EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanotechnology‐Enabled Blood Test for Oral Epithelial Disorders Management: A Proof‐of‐Concept Study

Erica Quagliarini, Giulio Caracciolo, Francesca Giulimondi, Federica Rocchetti iD, Gianluca Tenore, Lucia Borghetti, Laura Ottini, Valentino Valentini, Antonella Polimeni, Umberto Romeo

Oral Diseases · 2025

DOI: 10.1111/odi.15364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Erica Quagliarini und 9 weiteren Autor:innen. Beteiligte Einrichtung: NanoDelivery Lab, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Nanotechnology, Protein Corona. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To address the limitations and complexities associated with tissue biopsy, emerging nanotechnology methods show promise in enhancing the detection and management of oral squamous cell carcinoma and oral potential malignant disorders. Among them, the characterization of the protein corona, the biomolecular layer that envelops materials when exposed to biological fluids, has recently emerged as a powerful tool for distinguishing oncological patients from healthy people. Materials and Methods Building upon recent insights, here we formulated a new diagnostic method for oral squamous cell carcinoma and oral potentially malignant disorders based on the characterization of the personalized protein corona formed on graphene oxide nanosheets when exposed to the plasma of the patients.

Results

The findings highlighted a discernible distinction between oncological subjects and healthy ones, resulting in an overall accuracy of 87%. Subsequently, we applied this method to monitor the progression of the diseases of the patients undergoing treatment, and we observed a trend indicating a convergence of protein profiles between oncological patients and healthy subjects throughout the treatment course.

Conclusion

If further confirmed in larger prospective studies, this new approach could discriminate oral squamous cell carcinoma and oral potentially malignant disorders and can be considered in the management of these oral diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCarcinoma, Squamous CellNanotechnologyProtein CoronaHumansProof of Concept StudyGraphiteMaleFemaleMiddle AgedAged

Stichwörter der Autor:innen

biomarkersblood testnanoparticlesoral canceroral potentially malignant disordersprotein corona

Substanzen

Protein CoronaGraphitegraphene oxide

Autor:innen und Institutionen

  • NanoDelivery Lab, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Rome, Italy.
  • Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

ORCID-Profile: Federica Rocchetti

Zitieren

APA

Quagliarini, E., Caracciolo, G., Giulimondi, F., Rocchetti, F., Tenore, G., Borghetti, L., Ottini, L., Valentini, V., Polimeni, A., & Romeo, U. (2025). Nanotechnology‐Enabled Blood Test for Oral Epithelial Disorders Management: A Proof‐of‐Concept Study. Oral Diseases. https://doi.org/10.1111/odi.15364

Vancouver

Quagliarini E, Caracciolo G, Giulimondi F, Rocchetti F, Tenore G, Borghetti L, et al. Nanotechnology‐Enabled Blood Test for Oral Epithelial Disorders Management: A Proof‐of‐Concept Study. Oral Diseases. 2025. doi:10.1111/odi.15364

BibTeX
@article{Quagliarini2025,
  author = {Quagliarini, Erica and Caracciolo, Giulio and Giulimondi, Francesca and Rocchetti, Federica and Tenore, Gianluca and Borghetti, Lucia and Ottini, Laura and Valentini, Valentino and Polimeni, Antonella and Romeo, Umberto},
  title = {Nanotechnology‐Enabled Blood Test for Oral Epithelial Disorders Management: A Proof‐of‐Concept Study},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.15364}
}
Kostenlos starten →